JPRN-UMIN000014350已完成未知
Study on dose adjustment of insulin glargine in type 2 diabetic patients treated with basal supported oral therapy - Adjust KOBE
Kobe University Graduate School of Medicine0 个研究点目标入组 160 人开始时间: 2014年8月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 160
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional,observational
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •diabetes other than type 2 diabetes mellitus history of stroke, myocardial infarction, angina pectoris, coronary artery bypass graft, percutaneous transluminal coronary angioplasty or other severe cardiac disease within the preceding 12 months severe renal dysfunction (serum creatinine >2.0mg/dl) severe liver dysfunction (serum aspartate aminotransferase or alanine aminotransferase >=2.5 times the normal upper limit active proliferative diabetic retinopathy or none of ophthalmologic examination in the past 12 months history of hypoglycemia unawareness pregnancy or breast-feeding
研究者
相似试验
已完成
4 期
Effectiveness of Dose Adjustment of Insulin in Type 2 Diabetes among Hemodialysis Patients with End Stage Renal Disease: a Randomized Crossover StudyPlasma glucoseHypoglycemiaInsulinEnd stage renal diseaseType 2 diabetesInsulinHemodialysisGlycemic controlType 2 diabetes (T2DM)TCTR20180724002Phramongkutklao Hospital and College of Medicine51
已完成
Unknown
Artificial intelligence (AI)-powered mealtime insulin dose-assisted decision-making systemType 2 diabetesNutritional, Metabolic, EndocrineISRCTN16784568Peking University People's Hospital111
已完成
4 期
Evaluation of Toujeo Insulin in Type 2 Diabetes Patients Inadequately Control With Their Basal Insulin TreatmentDiabetes Mellitus, Type 2NCT02967237Sanofi136
已完成
2 期
Insulin glargine and acarbose in the treatment of type II diabetesDiabet mellitus.non insulin dependent diabetes mellitusIRCT201403041774N6Physiology research center, Vice chancellor for Research and Technology of kerman medical University152
进行中（未招募）
不适用
Prospective influence of bedtime insulin glargine on mobilization and function of endothelial progenitor cells in patients with type 2 diabetes: a partially double-blind, randomized, three-arm unicenter study - Glargine and EPCThe medical disease that will be investigated is type 2, diabetes mellitus. The patients who will be investigated are between 35 and 70 years old and on oral antidiabetic therapy.MedDRA version: 9.1Level: LLTClassification code 10045242Term: Type II diabetes mellitusEUCTR2006-006573-24-DEniversity Hospital of Heidelberg